Parmax Pharma Limited (BOM:540359)
India · Delayed Price · Currency is INR 66.69
+1.30 (1.99%)
At close: Jun 17, 2026
Parmax Pharma Market Cap
Parmax Pharma has a market cap or net worth of 249.51 million as of June 18, 2026. Its market cap has increased by 51.57% in one year.
Market Cap
249.51M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
66.69
Market Cap Chart
Since July 26, 2019, Parmax Pharma's market cap has increased from 67.90M to 249.51M, an increase of 267.44%. That is a compound annual growth rate of 20.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 249.51M | 97.13% |
| Dec 31, 2025 | 126.57M | -23.55% |
| Dec 31, 2024 | 165.55M | 35.86% |
| Dec 29, 2023 | 121.85M | -15.84% |
| Dec 30, 2022 | 144.79M | -35.45% |
| Dec 31, 2021 | 224.29M | 103.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Welcure Drugs and Pharmaceuticals | 346.06M |
| Panjon | 315.48M |
| JFL Life Sciences | 311.81M |
| Deccan Health Care | 296.33M |
| Gujarat Terce Laboratories | 264.59M |
| Walpar Nutritions | 225.84M |
| Hamps Bio | 225.21M |
| Rekvina Laboratories | 221.35M |